MoneyWorks4Me

Lupin board recommends Final Dividend

07 May 2014 Evaluate

Lupin has informed that the Board of Directors of the company at its meeting held on May 07, 2014, has recommended final dividend at the rate of 150% i.e. Rs 3 per equity share of the face value of Rs 2 each for the year ended March 31, 2014 subject to the approval of the shareholders at the ensuing Annual General Meeting. The Board of Directors had at their meeting held on February 03, 2014, declared and paid interim dividend of Rs 3 per equity share of Rs 2 each. Thus, the total dividend for the year ended March 31, 2014 would be Rs 6 per equity share.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1833.85
Dr. Reddys Labs. 1220.00
Cipla 1372.10
Lupin 2055.00
Zydus Lifesciences 1194.80
View more..